nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—AHR—Adipogenesis—E2F4—ocular cancer	0.0307	0.0307	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—RBL1—ocular cancer	0.0301	0.0301	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—RBL2—ocular cancer	0.0276	0.0276	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.0266	0.0266	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—CRTC1—ocular cancer	0.0266	0.0266	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—ID2—ocular cancer	0.0237	0.0237	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.023	0.023	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.022	0.022	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.0189	0.0189	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—ID2—ocular cancer	0.0168	0.0168	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0155	0.0155	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.0152	0.0152	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0149	0.0149	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—MAML2—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CCND3—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.0125	0.0125	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.012	0.012	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—GNA11—ocular cancer	0.0119	0.0119	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—E2F1—ocular cancer	0.0116	0.0116	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—GNAQ—ocular cancer	0.011	0.011	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—HDAC1—ocular cancer	0.0108	0.0108	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CDK6—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—HDAC1—ocular cancer	0.00995	0.00995	CbGpPWpGaD
Flutamide—AR—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.00978	0.00978	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00887	0.00887	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—E2F1—ocular cancer	0.00886	0.00886	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00883	0.00883	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00839	0.00839	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—RB1—ocular cancer	0.00822	0.00822	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.00764	0.00764	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.00749	0.00749	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00747	0.00747	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDC25A—ocular cancer	0.00745	0.00745	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00729	0.00729	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ocular cancer	0.00704	0.00704	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC1—ocular cancer	0.00704	0.00704	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.00697	0.00697	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—CDK4—ocular cancer	0.00667	0.00667	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—HDAC1—ocular cancer	0.00646	0.00646	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00644	0.00644	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—RB1—ocular cancer	0.00628	0.00628	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.00624	0.00624	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00622	0.00622	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—CDKN1A—ocular cancer	0.00591	0.00591	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00542	0.00542	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00529	0.00529	CbGpPWpGaD
Flutamide—AR—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.00515	0.00515	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00498	0.00498	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00494	0.00494	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—CDKN1B—ocular cancer	0.00489	0.00489	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—TGFB1—ocular cancer	0.00488	0.00488	CbGpPWpGaD
Flutamide—AR—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00486	0.00486	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00467	0.00467	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.0046	0.0046	CbGpPWpGaD
Flutamide—AR—FOXA1 transcription factor network—EP300—ocular cancer	0.00453	0.00453	CbGpPWpGaD
Flutamide—CYP1B1—Tryptophan metabolism—MDM2—ocular cancer	0.00451	0.00451	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00434	0.00434	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—EP300—ocular cancer	0.00429	0.00429	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00423	0.00423	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Flutamide—AR—Nongenotropic Androgen signaling—HRAS—ocular cancer	0.0041	0.0041	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—EP300—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Flutamide—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.0039	0.0039	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0038	0.0038	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.00379	0.00379	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.00377	0.00377	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.00372	0.00372	CbGpPWpGaD
Flutamide—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00326	0.00326	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.00321	0.00321	CbGpPWpGaD
Flutamide—AR—Gene Expression—SF3B1—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00315	0.00315	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00315	0.00315	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00314	0.00314	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00305	0.00305	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00301	0.00301	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.003	0.003	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.003	0.003	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00292	0.00292	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00284	0.00284	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—ocular cancer	0.00284	0.00284	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Flutamide—CYP1A1—Tryptophan metabolism—MDM2—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.00271	0.00271	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00254	0.00254	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—ocular cancer	0.00253	0.00253	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00249	0.00249	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00244	0.00244	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00242	0.00242	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.00238	0.00238	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Flutamide—AR—Gene Expression—EIF1AX—ocular cancer	0.00224	0.00224	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00223	0.00223	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PSPH—ocular cancer	0.00205	0.00205	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Flutamide—AR—Gene Expression—E2F5—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Flutamide—AR—Gene Expression—E2F4—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Flutamide—AR—Gene Expression—RPL39—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Flutamide—AR—Gene Expression—RBL1—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Flutamide—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.00177	0.00177	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00164	0.00164	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Flutamide—AR—Gene Expression—RBBP4—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Flutamide—AR—Gene Expression—TFDP1—ocular cancer	0.00144	0.00144	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00142	0.00142	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PSPH—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PSPH—ocular cancer	0.00126	0.00126	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00121	0.00121	CbGpPWpGaD
Flutamide—AR—Gene Expression—MAML2—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Flutamide—CYP1A1—PPARA activates gene expression—EP300—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Flutamide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PSPH—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.001	0.001	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000972	0.000972	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000845	0.000845	CbGpPWpGaD
Flutamide—AR—Gene Expression—HDAC1—ocular cancer	0.000839	0.000839	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PSPH—ocular cancer	0.000805	0.000805	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—ocular cancer	0.000752	0.000752	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.000748	0.000748	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNA11—ocular cancer	0.000645	0.000645	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PSPH—ocular cancer	0.000621	0.000621	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GNAQ—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000484	0.000484	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNA11—ocular cancer	0.00042	0.00042	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNA11—ocular cancer	0.000397	0.000397	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000391	0.000391	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GNAQ—ocular cancer	0.000369	0.000369	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNA11—ocular cancer	0.000325	0.000325	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000302	0.000302	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—ocular cancer	0.000291	0.000291	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNA11—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000244	0.000244	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GNAQ—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—EP300—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNA11—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000182	0.000182	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—EP300—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—EP300—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—EP300—ocular cancer	0.000109	0.000109	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—ocular cancer	8.49e-05	8.49e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—EP300—ocular cancer	8.46e-05	8.46e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—ocular cancer	8.02e-05	8.02e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—ocular cancer	6.56e-05	6.56e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—EP300—ocular cancer	6.53e-05	6.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—ocular cancer	5.11e-05	5.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—ocular cancer	3.95e-05	3.95e-05	CbGpPWpGaD
